» Articles » PMID: 38252832

Single-particle Imaging of Nanomedicine Entering the Brain

Overview
Specialty Science
Date 2024 Jan 22
PMID 38252832
Authors
Affiliations
Soon will be listed here.
Abstract

Nanomedicine has emerged as a revolutionary strategy of drug delivery. However, fundamentals of the nano-neuro interaction are elusive. In particular, whether nanocarriers can cross the blood-brain barrier (BBB) and release the drug cargo inside the brain, a basic process depicted in numerous books and reviews, remains controversial. Here, we develop an optical method, based on stimulated Raman scattering, for imaging nanocarriers in tissues. Our method achieves a suite of capabilities-single-particle sensitivity, chemical specificity, and particle counting capability. With this method, we visualize individual intact nanocarriers crossing the BBB of mouse brains and quantify the absolute number by particle counting. The fate of nanocarriers after crossing the BBB shows remarkable heterogeneity across multiple scales. With a mouse model of aging, we find that blood-brain transport of nanocarriers decreases with age substantially. This technology would facilitate development of effective therapeutics for brain diseases and clinical translation of nanocarrier-based treatment in general.

Citing Articles

Absolute signal of stimulated Raman scattering microscopy: A quantum electrodynamics treatment.

Min W, Gao X Sci Adv. 2024; 10(50):eadm8424.

PMID: 39661687 PMC: 11633754. DOI: 10.1126/sciadv.adm8424.


Innovative Approaches for Drug Discovery: Quantifying Drug Distribution and Response with Raman Imaging.

Dunnington E, Wong B, Fu D Anal Chem. 2024; 96(20):7926-7944.

PMID: 38625100 PMC: 11108735. DOI: 10.1021/acs.analchem.4c01413.

References
1.
Farrall A, Wardlaw J . Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis. Neurobiol Aging. 2007; 30(3):337-52. DOI: 10.1016/j.neurobiolaging.2007.07.015. View

2.
Huang C, Lee Y . Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Int J Pharm. 2006; 325(1-2):132-9. DOI: 10.1016/j.ijpharm.2006.06.008. View

3.
Johnsen K, Burkhart A, Melander F, Kempen P, Vejlebo J, Siupka P . Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. Sci Rep. 2017; 7(1):10396. PMC: 5583399. DOI: 10.1038/s41598-017-11220-1. View

4.
. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017; 16(11):877-897. PMC: 5641502. DOI: 10.1016/S1474-4422(17)30299-5. View

5.
Naqvi S, Panghal A, Flora S . Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front Neurosci. 2020; 14:494. PMC: 7297271. DOI: 10.3389/fnins.2020.00494. View